188 related articles for article (PubMed ID: 19813190)
1. Skeletal muscle cell MHC I expression: implications for statin-induced myopathy.
Singh P; Kohr D; Kaps M; Blaes F
Muscle Nerve; 2010 Feb; 41(2):179-84. PubMed ID: 19813190
[TBL] [Abstract][Full Text] [Related]
2. Progressive myopathy with up-regulation of MHC-I associated with statin therapy.
Needham M; Fabian V; Knezevic W; Panegyres P; Zilko P; Mastaglia FL
Neuromuscul Disord; 2007 Feb; 17(2):194-200. PubMed ID: 17241784
[TBL] [Abstract][Full Text] [Related]
3. Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy.
Stringer HA; Sohi GK; Maguire JA; Côté HC
J Neurol Sci; 2013 Feb; 325(1-2):142-7. PubMed ID: 23312852
[TBL] [Abstract][Full Text] [Related]
4. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
5. Statin-associated necrotizing autoimmune myopathy.
Fernandes GH; Zanoteli E; Shinjo SK
Mod Rheumatol; 2014 Sep; 24(5):862-4. PubMed ID: 24517559
[TBL] [Abstract][Full Text] [Related]
6. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
[TBL] [Abstract][Full Text] [Related]
7. MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin.
Stemme S; Fager G; Hansson GK
Immunology; 1990 Feb; 69(2):243-9. PubMed ID: 2106484
[TBL] [Abstract][Full Text] [Related]
8. Statin induced myopathy.
Frank RE
J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
[TBL] [Abstract][Full Text] [Related]
9. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction.
Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R
Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
12. Statin myopathy: a review of recent progress.
Mammen AL; Amato AA
Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.
Nishimoto T; Ishikawa E; Anayama H; Hamajyo H; Nagai H; Hirakata M; Tozawa R
Toxicol Appl Pharmacol; 2007 Aug; 223(1):39-45. PubMed ID: 17599378
[TBL] [Abstract][Full Text] [Related]
14. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
15. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
Mullen PJ; Lüscher B; Scharnagl H; Krähenbühl S; Brecht K
Biochem Pharmacol; 2010 Apr; 79(8):1200-9. PubMed ID: 20018177
[TBL] [Abstract][Full Text] [Related]
16. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
Waschbisch A; Wintterle S; Lochmüller H; Walter MC; Wischhusen J; Kieseier BC; Wiendl H
Arthritis Rheum; 2008 Nov; 58(11):3600-8. PubMed ID: 18975328
[TBL] [Abstract][Full Text] [Related]
17. Statins as immunomodulatory agents.
Mach F
Circulation; 2004 Jun; 109(21 Suppl 1):II15-7. PubMed ID: 15173058
[TBL] [Abstract][Full Text] [Related]
18. Clinical characterization and molecular mechanisms of statin myopathy.
Toth PP; Harper CR; Jacobson TA
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):955-69. PubMed ID: 18666846
[TBL] [Abstract][Full Text] [Related]
19. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.
Skottheim IB; Gedde-Dahl A; Hejazifar S; Hoel K; Asberg A
Eur J Pharm Sci; 2008 Apr; 33(4-5):317-25. PubMed ID: 18294823
[TBL] [Abstract][Full Text] [Related]
20. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment.
Duncan AJ; Hargreaves IP; Damian MS; Land JM; Heales SJ
Toxicol Mech Methods; 2009 Jan; 19(1):44-50. PubMed ID: 19778232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
